Becatecarin is a derivative of rebeccamycin.
Investigated for use/treatment in cancer/tumors (unspecified), liver cancer, gastric cancer, and leukemia (unspecified).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.